The relation of thrombomodulin G33A and C1418T gene polymorphisms to the risk of acute myocardial infarction in Egyptians

Background: Acute myocardial infarction (AMI) is one of the major causes of morbidity and mortality worldwide. There is an increased interest in the genetic risk factors in the pathogenesis of ischemic heart disease. Thrombomodulin (TM), a natural anticoagulant, may play a critical role in the patho...

Full description

Bibliographic Details
Main Authors: Wael Alkhiary, Mohamed Abdalaal, Amr Mohamed El-Saddik
Format: Article
Language:English
Published: SpringerOpen 2018-01-01
Series:Egyptian Journal of Medical Human Genetics
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1110863017300794
_version_ 1819172969543368704
author Wael Alkhiary
Mohamed Abdalaal
Amr Mohamed El-Saddik
author_facet Wael Alkhiary
Mohamed Abdalaal
Amr Mohamed El-Saddik
author_sort Wael Alkhiary
collection DOAJ
description Background: Acute myocardial infarction (AMI) is one of the major causes of morbidity and mortality worldwide. There is an increased interest in the genetic risk factors in the pathogenesis of ischemic heart disease. Thrombomodulin (TM), a natural anticoagulant, may play a critical role in the pathogenesis of AMI. Aim of the study: To assess whether Thrombomodulin (TM) G33A and C1418T gene polymorphisms are related to the risk of AMI in Egyptians or not. Subjects and methods: 102 AMI patients were recruited vs 110 healthy controls. For every subject, measurement of plasma soluble Thrombomodulin level was done by enzyme-linked immunosorbent assay (ELISA). Further, DNA samples were genotyped by PCR-RFLP method for the TM G33A polymorphism and by PCR-ASO for the TM C1418T polymorphism. Results: Our results revealed that the C1418T gene polymorphism was significantly associated with increased risk of AMI (CT: OR = 2.34, 95% CI = 1.28–4.29, P = 0.006; TT: OR = 8.03, 95% CI = 0.97–66.47, P = 0.026; CT + TT: OR = 2.65, 95% CI = 1.47–4.78, P = 0.001; T allele: OR = 2.51, 95% CI = 1.51–4.18, P < 0.001). On the other side, the TM G33A polymorphism was not detectable in any of patients or controls. Further, plasma soluble TM concentrations were higher in AMI patients, compared to the control group (P < 0.001). Conclusions: TM 1418 C > T gene polymorphism, but not TM 33-G > A, may be associated with an increased risk of AMI in the Egyptian population. These results may have clinical implication in the management of AMI in the future.
first_indexed 2024-12-22T20:15:38Z
format Article
id doaj.art-c945bc24aaff437690ce94d9e2f3442e
institution Directory Open Access Journal
issn 1110-8630
language English
last_indexed 2024-12-22T20:15:38Z
publishDate 2018-01-01
publisher SpringerOpen
record_format Article
series Egyptian Journal of Medical Human Genetics
spelling doaj.art-c945bc24aaff437690ce94d9e2f3442e2022-12-21T18:13:58ZengSpringerOpenEgyptian Journal of Medical Human Genetics1110-86302018-01-01191192210.1016/j.ejmhg.2017.08.007The relation of thrombomodulin G33A and C1418T gene polymorphisms to the risk of acute myocardial infarction in EgyptiansWael Alkhiary0Mohamed Abdalaal1Amr Mohamed El-Saddik2Department of Clinical Pathology, Mansoura Faculty of Medicine, Mansoura University, EgyptDepartment of Cardiology, Tanta University Hospital, Tanta University, EgyptDepartment of Clinical Pathology, Mansoura Faculty of Medicine, Mansoura University, EgyptBackground: Acute myocardial infarction (AMI) is one of the major causes of morbidity and mortality worldwide. There is an increased interest in the genetic risk factors in the pathogenesis of ischemic heart disease. Thrombomodulin (TM), a natural anticoagulant, may play a critical role in the pathogenesis of AMI. Aim of the study: To assess whether Thrombomodulin (TM) G33A and C1418T gene polymorphisms are related to the risk of AMI in Egyptians or not. Subjects and methods: 102 AMI patients were recruited vs 110 healthy controls. For every subject, measurement of plasma soluble Thrombomodulin level was done by enzyme-linked immunosorbent assay (ELISA). Further, DNA samples were genotyped by PCR-RFLP method for the TM G33A polymorphism and by PCR-ASO for the TM C1418T polymorphism. Results: Our results revealed that the C1418T gene polymorphism was significantly associated with increased risk of AMI (CT: OR = 2.34, 95% CI = 1.28–4.29, P = 0.006; TT: OR = 8.03, 95% CI = 0.97–66.47, P = 0.026; CT + TT: OR = 2.65, 95% CI = 1.47–4.78, P = 0.001; T allele: OR = 2.51, 95% CI = 1.51–4.18, P < 0.001). On the other side, the TM G33A polymorphism was not detectable in any of patients or controls. Further, plasma soluble TM concentrations were higher in AMI patients, compared to the control group (P < 0.001). Conclusions: TM 1418 C > T gene polymorphism, but not TM 33-G > A, may be associated with an increased risk of AMI in the Egyptian population. These results may have clinical implication in the management of AMI in the future.http://www.sciencedirect.com/science/article/pii/S1110863017300794ThrombomodulinAcute myocardial infarctionPolymorphismGenetic
spellingShingle Wael Alkhiary
Mohamed Abdalaal
Amr Mohamed El-Saddik
The relation of thrombomodulin G33A and C1418T gene polymorphisms to the risk of acute myocardial infarction in Egyptians
Egyptian Journal of Medical Human Genetics
Thrombomodulin
Acute myocardial infarction
Polymorphism
Genetic
title The relation of thrombomodulin G33A and C1418T gene polymorphisms to the risk of acute myocardial infarction in Egyptians
title_full The relation of thrombomodulin G33A and C1418T gene polymorphisms to the risk of acute myocardial infarction in Egyptians
title_fullStr The relation of thrombomodulin G33A and C1418T gene polymorphisms to the risk of acute myocardial infarction in Egyptians
title_full_unstemmed The relation of thrombomodulin G33A and C1418T gene polymorphisms to the risk of acute myocardial infarction in Egyptians
title_short The relation of thrombomodulin G33A and C1418T gene polymorphisms to the risk of acute myocardial infarction in Egyptians
title_sort relation of thrombomodulin g33a and c1418t gene polymorphisms to the risk of acute myocardial infarction in egyptians
topic Thrombomodulin
Acute myocardial infarction
Polymorphism
Genetic
url http://www.sciencedirect.com/science/article/pii/S1110863017300794
work_keys_str_mv AT waelalkhiary therelationofthrombomoduling33aandc1418tgenepolymorphismstotheriskofacutemyocardialinfarctioninegyptians
AT mohamedabdalaal therelationofthrombomoduling33aandc1418tgenepolymorphismstotheriskofacutemyocardialinfarctioninegyptians
AT amrmohamedelsaddik therelationofthrombomoduling33aandc1418tgenepolymorphismstotheriskofacutemyocardialinfarctioninegyptians
AT waelalkhiary relationofthrombomoduling33aandc1418tgenepolymorphismstotheriskofacutemyocardialinfarctioninegyptians
AT mohamedabdalaal relationofthrombomoduling33aandc1418tgenepolymorphismstotheriskofacutemyocardialinfarctioninegyptians
AT amrmohamedelsaddik relationofthrombomoduling33aandc1418tgenepolymorphismstotheriskofacutemyocardialinfarctioninegyptians